Clinical trials
Phase 3 Coronavirus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 27 |
| 2021 | 14 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Terminated | 10 |
| Recruiting | 6 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 10 |
| BioNTech SE | 6 |
| ModernaTX, Inc. | 4 |
| Eli Lilly and Company | 2 |
| Northwell Health | 2 |
| Novartis Pharmaceuticals | 2 |
| Novavax | 2 |
| Pfizer | 2 |
| University of Minnesota | 2 |
| Washington University School of Medicine | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronavirus Infections | 52 |
| COVID-19 | 47 |
| Virus Diseases | 21 |
| Severe Acute Respiratory Syndrome | 18 |
| RNA Virus Infections | 15 |
| Coronaviridae Infections | 14 |
| Nidovirales Infections | 13 |
| Lung Diseases | 6 |
| Respiratory Tract Infections | 6 |
| Infections | 5 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.